Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)
Department of Health and Human Services National Institutes of Health
Posted on:
Fecha de Cierre:
Expired
Tipo
Research/project funding
Reference Number
RFA-AG-23-011
The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs implicated in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). This FOA will support exploratory and developmental Grant (R21) applications seeking to discover functional roles of ncRNAs and underlying mechanisms involved in the pathogenesis and progression of AD/ADRD. Proposed studies should focus on functional characterization and mechanistic investigation of previously identified ncRNAs.
Categories: Health.
Categories: Health.
Estados Unidos